Watch ALLO. Know when insiders buy.
One email the day a filing lands. Free.
ALLO
Allogene Therapeutics, Inc.
1.33
−0.00 −0.38%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
48
WATCH · insiders 47, shorts 49
Insiders, 90 days
−$63K
net selling · 0 buys, 1 sell
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $457.8MP/E —DIV YIELD —FCF YIELD -22.41%REV TTM —NET INCOME −$165.5MNET CASH —52W 1.05 – 3.06SEC XBRL · TTM TO Invalid Date
Who holds it
None of the 15 tracked funds disclose ALLO in their latest 13F. The funds we follow.
13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.
Stakes of 5% or more
TPG GP A, LLC and 2 related0.0%
“This Amendment amends and supplements Item 4 of the Original Schedule 13D by inserting the following after the two paragraphs titled "August 2020 Distribution in Kind": "On September 28, 2026, the TPG Funds sold an aggregate of 18,716,306 shares of Common Stock at a price of $1.55 per share pursuant…”
A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.